Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors.

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol (2008) 3.30

Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol (2008) 2.38

Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05

Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology (2009) 1.98

Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97

Response analysis for multiple symptoms revealed differences between arms of a symptom management trial. J Clin Epidemiol (2009) 1.73

Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial. Cancer (2011) 1.67

How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil (2011) 1.64

Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer (2004) 1.56

A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer (2008) 1.52

Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep (2008) 1.50

Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol (2005) 1.47

Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun (2007) 1.42

Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics (2009) 1.40

Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun (2010) 1.36

Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36

Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol (2014) 1.29

Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25

ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23

A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun (2012) 1.20

Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer (2014) 1.17

Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer (2010) 1.16

I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res (2010) 1.16

Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer (2006) 1.16

Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomised controlled trial. Support Care Cancer (2004) 1.15

Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst (2013) 1.11

Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med (2004) 1.10

Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer (2011) 1.09

Childhood Adversity and Cumulative Life Stress: Risk Factors for Cancer-Related Fatigue. Clin Psychol Sci (2014) 1.01

Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int (2012) 0.99

Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv (2010) 0.98

Fatigue after treatment in breast cancer survivors: prevalence, determinants and impact on health-related quality of life. Support Care Cancer (2011) 0.97

Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer (2008) 0.97

Cancer survivors' responses to daily stressors: implications for quality of life. Health Psychol (2012) 0.96

Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J Pain Symptom Manage (2011) 0.96

A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol (2013) 0.96

The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer (2013) 0.93

Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer (2010) 0.92

Mechanisms of chemotherapy-induced behavioral toxicities. Front Neurosci (2015) 0.92

Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patients. Health Qual Life Outcomes (2011) 0.91

Breast Cancer and Fatigue. Sleep Med Clin (2008) 0.91

A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care (2012) 0.91

Skeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humans. Front Physiol (2014) 0.89

Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review. Oncol Hematol Rev (2012) 0.89

Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid (2013) 0.89

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. Br J Cancer (2002) 0.88

Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS One (2014) 0.87

Quality of life outcomes in patients with anal cancer after combined radiochemotherapy. Strahlenther Onkol (2011) 0.87

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer (2014) 0.86

A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatology (Oxford) (2008) 0.86

Conducting routine fatigue assessments for use in clinical oncology practice: patient and provider perspectives. Support Care Cancer (2007) 0.86

Fatigue in cancer: a review of literature. Indian J Palliat Care (2009) 0.86

A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer. J Support Oncol (2013) 0.85

The Relationship between Qi Deficiency, Cancer-related Fatigue and Quality of Life in Cancer Patients. J Tradit Complement Med (2012) 0.85

Cancer-related fatigue: the approach and treatment. J Gen Intern Med (2009) 0.84

Factors associated with response to methylphenidate in advanced cancer patients. Oncologist (2011) 0.84

The Prognostic Importance of Frailty in Cancer Survivors. J Am Geriatr Soc (2015) 0.84

The effectiveness and safety of moxibustion for treating cancer-related fatigue: a systematic review and meta-analyses. Support Care Cancer (2014) 0.82

Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors. Support Care Cancer (2012) 0.82

Mistletoe treatment in cancer-related fatigue: a case report. Cases J (2009) 0.82

The correlation of traditional chinese medicine deficiency syndromes, cancer related fatigue, and quality of life in breast cancer patients. J Tradit Complement Med (2012) 0.82

The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol. BMC Cancer (2012) 0.82

Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods. J Clin Epidemiol (2009) 0.82

Breast cancer survivorship issues. Hematol Oncol Clin North Am (2013) 0.82

Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression. Support Care Cancer (2005) 0.81

Fatigue assessment and rehabilitation outcomes in patients with brain tumors. Support Care Cancer (2011) 0.81

Factors affecting quality of life and fatigue in patients with leukemia under chemotherapy. J Educ Health Promot (2014) 0.80

Fee-for-service cancer rehabilitation programs improve health-related quality of life. Curr Oncol (2016) 0.80

Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study. Qual Life Res (2013) 0.80

Correspondence between daily and weekly fatigue reports in breast cancer survivors. J Behav Med (2006) 0.80

Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy. J Pain Symptom Manage (2014) 0.80

Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study. J Cancer Surviv (2014) 0.80

Aiming for a better understanding and management of cancer-related fatigue. Oncologist (2013) 0.80

Effect of a structured, active, home-based cancer-treatment program for the management of patients on oral chemotherapy. Patient Prefer Adherence (2014) 0.79

A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma. Support Care Cancer (2014) 0.79

An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan. BMC Cancer (2011) 0.79

Interest in Health Behavior Intervention Delivery Modalities Among Cancer Survivors: A Cross-Sectional Study. JMIR Cancer (2016) 0.79

Physical and mental health trajectories of cancer patients and caregivers across the year post-diagnosis: a dyadic investigation. Psychol Health (2016) 0.79

Effectiveness, Mediators, and Effect Predictors of Internet Interventions for Chronic Cancer-Related Fatigue: The Design and an Analysis Plan of a 3-Armed Randomized Controlled Trial. JMIR Res Protoc (2015) 0.79

Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. PLoS One (2015) 0.77

Assessment of daily and weekly fatigue among African American cancer survivors. J Psychosoc Oncol (2013) 0.77

Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases. Biology (Basel) (2014) 0.77

Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol (2017) 0.76

Attachment style and respiratory sinus arrhythmia predict post-treatment quality of life in breast cancer survivors. Psychooncology (2014) 0.76

Subgroups of cancer patients with unique pain and fatigue experiences during chemotherapy. J Pain Symptom Manage (2014) 0.76

Assessing cancer-related fatigue: the psychometric properties of the Revised Piper Fatigue Scale in Italian cancer inpatients. Support Care Cancer (2009) 0.76

Evaluation and management of fatigue in oncology: a multidimensional approach. Indian J Palliat Care (2011) 0.76

Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population. Support Care Cancer (2014) 0.76

Evidence of significant central fatigue in patients with cancer-related fatigue during repetitive elbow flexions till perceived exhaustion. PLoS One (2014) 0.75

Headache types, related morbidity, and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross sectional study. Eur J Paediatr Neurol (2014) 0.75

Quality of life after cancer-How the extent of impairment is influenced by patient characteristics. BMC Cancer (2016) 0.75

Quality of life of women with breast cancer undergoing radiotherapy using the Functional Assessment of Chronic Illness Therapy-Fatigue questionnaire. Clin Interv Aging (2016) 0.75

Concerns about Breast Cancer, Pain, and Fatigue in Non-Metastatic Breast Cancer Patients Undergoing Primary Treatment. Healthcare (Basel) (2016) 0.75

A comparison of disrupted sleep patterns in women with cancer-related fatigue and postmenopausal women without cancer. Eur J Oncol Nurs (2010) 0.75

Development and evaluation of a cancer-related fatigue patient education program: protocol of a randomized controlled trial. BMC Nurs (2008) 0.75

Diet components associated with perceived fatigue in breast cancer survivors. Eur J Cancer Care (Engl) (2012) 0.75

Patient and health care provider perceptions of cancer-related fatigue and pain. Support Care Cancer (2016) 0.75

The course of fatigue in patients with gynecologic and breast cancer. J Gynecol Oncol (2013) 0.75

Definition, prevalence and characteristics of sudden exhaustion: a possible syndrome of fatigue in cancer? Support Care Cancer (2012) 0.75

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis. Support Care Cancer (2017) 0.75

Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med (1998) 5.50

Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev (2002) 5.29

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis (1998) 4.50

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med (1995) 4.12

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62

Population policy: will current programs succeed? Grounds for skepticism concerning the demographic effectiveness of family planning are considered. Science (1967) 3.55

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med (1996) 3.41

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27

Uninsured and underserved: inequities in health care in the United States. Milbank Mem Fund Q Health Soc (1983) 3.16

Physicians' views on quality of care: a five-country comparison. Health Aff (Millwood) (2001) 3.00

The theory of change and response in modern demographic history. Popul Index (1963) 2.95

Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation (1979) 2.87

Insurance matters for low-income adults: results from a five-state survey. Health Aff (Millwood) (1997) 2.60

Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum (2000) 2.41

Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36

Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg (1996) 2.30

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis (1999) 2.24

Access to health care for the poor: does the gap remain? Annu Rev Public Health (1981) 2.17

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology (1996) 2.13

Progress toward guidelines for the management of fatigue. Oncology (Williston Park) (1998) 2.12

Health insurance markets and income inequality: findings from an international health policy survey. Health Policy (2000) 2.04

Utilizing a line maintenance team to reduce central-line-associated bloodstream infections in a neonatal intensive care unit. J Perinatol (2011) 2.01

The cost of health system change: public discontent in five nations. Health Aff (Millwood) (1999) 1.98

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet (1997) 1.96

Equal treatment and unequal benefits: the Medicare program. Milbank Mem Fund Q Health Soc (1975) 1.74

Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol (1981) 1.74

Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis (1995) 1.69

Penetrating cardiac trauma: a perioperative role for transesophageal echocardiography. Anesth Analg (1993) 1.68

Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage (1999) 1.68

The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. Nature (1997) 1.58

Stress and burnout in oncology. Oncology (Williston Park) (2000) 1.56

Ictal neocortical slowing in temporal lobe epilepsy. Neurology (2004) 1.55

Listening to parents. A national survey of parents with young children. Arch Pediatr Adolesc Med (1998) 1.52

An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci U S A (1998) 1.49

The accuracy of tympanic temperature measurement in children. Pediatr Nurs (1993) 1.48

Surgical survival in the Coronary Artery Surgery Study (CASS) registry. Ann Thorac Surg (1985) 1.44

Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med (1994) 1.44

Positive end-expiratory pressure and response to inhaled nitric oxide: changing nonresponders to responders. Surgery (2000) 1.44

Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol (1992) 1.42

Cost and complications during in-hospital transport of critically ill patients: a prospective cohort study. J Trauma (1992) 1.40

Attribution of injury to alcohol involvement in young adults seriously injured in alcohol-related motor vehicle crashes. Am J Crit Care (2000) 1.40

The federal budget and women's health. Am J Public Health (1995) 1.39

Screening and treatment of distress. J Consult Clin Psychol (2001) 1.38

Improving outpatient diabetes management through a collaboration of six competing, capitated Medicare managed care plans. Am J Med Qual (2000) 1.37

Assessment of mortality rates for congenital heart defects and surgeons' performance. Ann Thorac Surg (2001) 1.36

Pain syndromes and etiologies in ambulatory AIDS patients. Pain (1997) 1.35

The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage (2001) 1.33

Racial and ethnic differences in drug treatment entry of injection drug users in Massachusetts. J Subst Abuse Treat (2001) 1.29

Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death. Am J Psychiatry (1999) 1.29

Primary care and psychiatry: anticipating an interfaith marriage. Acad Med (1999) 1.29

Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend (2000) 1.25

Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev (2001) 1.25

Total axillary lymphadenectomy in the management of breast cancer. Arch Surg (1991) 1.24

Uninsured in an era of managed care. Health Serv Res (1997) 1.23

Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med (2001) 1.22

Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation (1984) 1.21

Medicaid payments and utilization of medical services by the poor. Inquiry (1976) 1.21

Mutational analysis of exoribonuclease I from Saccharomyces cerevisiae. Nucleic Acids Res (1998) 1.20

Cancer in south Florida Hispanic women. A 9-year assessment. Arch Intern Med (1994) 1.20

A comparison of the enzymological and biophysical properties of two distinct classes of dehydroquinase enzymes. Biochem J (1992) 1.19

The migrations of human populations. Sci Am (1974) 1.18

The effect of early versus late fasciotomy in the management of extremity trauma. Surgery (1997) 1.17

The schedule of attitudes toward hastened death: Measuring desire for death in terminally ill cancer patients. Cancer (2000) 1.17

Source location of a 50 msec latency auditory evoked field component. Electroencephalogr Clin Neurophysiol (1988) 1.17

The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res (1997) 1.16

Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of life. Pain (1996) 1.16

Cellular signaling with nitric oxide and cyclic guanosine monophosphate. Semin Perinatol (2000) 1.14

Differences in stage at presentation of breast and gynecologic cancers among whites, blacks, and Hispanics. Cancer (1994) 1.13

The 100 most-cited articles from JMB. J Mol Biol (1999) 1.13

The pathophysiologic changes following bile aspiration in a porcine lung model. Chest (1993) 1.11

Cancer and the experience of meaning: a group psychotherapy program for people with cancer. Am J Psychother (2000) 1.11

The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A. Blood (1993) 1.10

Isolation and characterization of krp, a dibasic endopeptidase required for cell viability in the fission yeast Schizosaccharomyces pombe. EMBO J (1994) 1.09

The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery (2000) 1.09

New developments in the market for rural health care. Res Health Econ (1979) 1.09

Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials. J Altern Complement Med (2000) 1.09

Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire. J Pain Symptom Manage (2002) 1.06

The elderly in five nations: the importance of universal coverage. Health Aff (Millwood) (2000) 1.06

Blunt carotid artery injuries. J Am Coll Surg (1997) 1.05

Calcium dependence of villin-induced actin depolymerization. Biochemistry (1984) 1.05

Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol (1997) 1.04

Impact of the in-house trauma surgeon on initial patient care, outcome, and cost. J Trauma (1997) 1.03

CASS Registry long term surgical survival. Coronary Artery Surgery Study. J Am Coll Cardiol (1999) 1.03

Clinical audit of the use of fresh-frozen plasma and platelets in a tertiary teaching hospital and the impact of a new transfusion request form. Intern Med J (2005) 1.02

The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy. Invest New Drugs (2009) 1.02

Coronary anatomy and left ventricular function in the first 12 hours of acute myocardial infarction: the Western Washington Randomized Intracoronary Streptokinase Trial. Circulation (1985) 1.02

Clinical and radiologic remission in reticulum cell sarcoma of the brain. Arch Neurol (1979) 1.01

IMBA Expert: internal dosimetry made simple. Radiat Prot Dosimetry (2003) 1.01

High-dose carboplatin in refractory ovarian cancer patients. J Clin Oncol (1987) 1.00

Flow cytometric analysis of immunoprecipitates: high-throughput analysis of protein phosphorylation and protein-protein interactions. Cytometry (2000) 1.00

Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation (1985) 1.00

Prospective, randomized comparison of epidural versus parenteral opioid analgesia in thoracic trauma. Ann Surg (1999) 1.00

Operative risk factors in patients with left main coronary-artery disease. N Engl J Med (1980) 0.99

Carbamoylation of brain glutamate receptors by a disulfiram metabolite. J Biol Chem (1997) 0.99

Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits. Lab Invest (1983) 0.99

Humidification in the intensive care unit. Prospective study of a new protocol utilizing heated humidification and a hygroscopic condenser humidifier. Chest (1993) 0.98